Search research articles
Contact Us
Filters
Showing results (151-160 of 189) with videos related to
Page
of 19
Sort By:
ACS Medicinal Chemistry Letters
|
October 18, 2019
Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks
Fabian Heider, Tatu Pantsar, Mark Kudolo, et al.
Journal of Medicinal Chemistry
|
December 22, 2011
Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases
Bassam Abu Thaher, Martina Arnsmann, Frank Totzke, et al.
RSC Medicinal Chemistry
|
August 4, 2025
A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2
Laura Hillebrand, Guiqun Wang, Alexander Rasch, et al.
Plos One
|
October 12, 2012
Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α production
Renata B Lacerda, Leandro L da Silva, Cleverton K F de Lima, et al.
ACS Pharmacology & Translational Science
|
August 19, 2022
Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune Cells
Julian Laux, Michael Forster, Laura Riexinger, et al.
European Journal of Medicinal Chemistry
|
November 26, 2013
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
Maria Letícia de Castro Barbosa, Lídia Moreira Lima, Roberta Tesch, et al.
Neuroimage
|
March 22, 2014
Quantifying inter-individual anatomical variability in the subcortex using 7 T structural MRI
M C Keuken, P-L Bazin, L Crown, et al.
Journal of Medicinal Chemistry
|
December 16, 2024
Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping Example
Pascal Sander, Martin P Schwalm, Andreas Krämer, et al.
ACS Omega
|
August 9, 2018
Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3
Francesco Ansideri, Joana T Macedo, Michael Eitel, et al.
Journal of Medicinal Chemistry
|
December 29, 2012
Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activity
Stefan Fischer, Heike K Wentsch, Svenja C Mayer-Wrangowski, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 189) with videos related to
Sort By:
Page
of 19
ACS Medicinal Chemistry Letters
|
October 18, 2019
Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks
Fabian Heider, Tatu Pantsar, Mark Kudolo, et al.
Journal of Medicinal Chemistry
|
December 22, 2011
Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinases
Bassam Abu Thaher, Martina Arnsmann, Frank Totzke, et al.
RSC Medicinal Chemistry
|
August 4, 2025
A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2
Laura Hillebrand, Guiqun Wang, Alexander Rasch, et al.
Plos One
|
October 12, 2012
Discovery of novel orally active anti-inflammatory N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that inhibit TNF-α production
Renata B Lacerda, Leandro L da Silva, Cleverton K F de Lima, et al.
ACS Pharmacology & Translational Science
|
August 19, 2022
Pharmacokinetic Optimization of Small Molecule Janus Kinase 3 Inhibitors to Target Immune Cells
Julian Laux, Michael Forster, Laura Riexinger, et al.
European Journal of Medicinal Chemistry
|
November 26, 2013
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
Maria Letícia de Castro Barbosa, Lídia Moreira Lima, Roberta Tesch, et al.
Neuroimage
|
March 22, 2014
Quantifying inter-individual anatomical variability in the subcortex using 7 T structural MRI
M C Keuken, P-L Bazin, L Crown, et al.
Journal of Medicinal Chemistry
|
December 16, 2024
Design, Synthesis, and Biochemical Evaluation of Novel MLK3 Inhibitors: A Target Hopping Example
Pascal Sander, Martin P Schwalm, Andreas Krämer, et al.
ACS Omega
|
August 9, 2018
Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3
Francesco Ansideri, Joana T Macedo, Michael Eitel, et al.
Journal of Medicinal Chemistry
|
December 29, 2012
Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activity
Stefan Fischer, Heike K Wentsch, Svenja C Mayer-Wrangowski, et al.
Page
of 19